Elevated levels of p-tau in plasma and CSF correlate strongly with neurofibrillary tangles, a hallmark of AD pathology, thereby providing a non-invasive method to track tau-related neurodegeneration [23, 24]. This evidence concerns the gene MAPT and Alzheimer disease.